This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Goldgene LLC. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovations of Natalia Ainciart in Biopharmaceuticals
Introduction
Natalia Ainciart is a prominent inventor based in Buenos Aires, Argentina. She has made significant contributions to the field of biopharmaceuticals, particularly through her innovative work on chimeric proteins. Her research focuses on the development of novel therapeutic agents and diagnostic tools.
Latest Patents
Natalia Ainciart holds a patent for "Isolated chimeric proteins of modified lumazine synthase." This patent includes isolated chimeric proteins that consist of up to ten copies of peptides, polypeptides, or protein domains inserted in the amino termini of the lumazine synthase enzyme. The patent also covers isolated nucleotide sequences that code for these chimeric proteins, as well as vectors, plasmids, and transformed cells used for expressing the proteins. Additionally, it includes monoclonal and polyclonal antibodies induced by the chimeric proteins, hybridomas producing these antibodies, and various applications such as vaccines and pharmaceutical compounds. The patent outlines a method to induce an immune response in higher organisms through the administration of effective amounts of these vaccines and compounds. Furthermore, it discusses the use of biosensors that incorporate the chimeric proteins and protein conjugates formed by the chimeric proteins and ligands.
Career Highlights
Natalia Ainciart is currently associated with Goldgene LLC, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of chimeric proteins and their potential applications in medicine.
Collaborations
Some of her notable collaborators include Fernando Alberto Goldbaum and Diego Andrés Laplagne. Their combined expertise has contributed to the success of various projects and innovations in the field.
Conclusion
Natalia Ainciart's contributions to the field of biopharmaceuticals through her innovative patents and collaborative efforts highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical science and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile